These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 20177102)
21. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients. Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM Breast J; 2014; 20(3):235-42. PubMed ID: 24750508 [TBL] [Abstract][Full Text] [Related]
23. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma. Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347 [TBL] [Abstract][Full Text] [Related]
24. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
25. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905 [TBL] [Abstract][Full Text] [Related]
26. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans. Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727 [TBL] [Abstract][Full Text] [Related]
31. Effect of hyperglycemia on brain and liver Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy. Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203 [TBL] [Abstract][Full Text] [Related]
33. Test-Retest Variability in Lesion SUV and Lesion SUR in Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598 [TBL] [Abstract][Full Text] [Related]
34. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related]
35. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT. Park YS; Park SH; Lee SS; Kim DY; Shin YM; Lee W; Lee SG; Yu ES Radiology; 2011 Mar; 258(3):760-6. PubMed ID: 21212369 [TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT. Keramida G; Hunter J; Dizdarevic S; Peters AM Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891 [TBL] [Abstract][Full Text] [Related]
37. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET. Lin CY; Lin WY; Lin CC; Shih CM; Jeng LB; Kao CH Clin Imaging; 2011; 35(6):437-41. PubMed ID: 22040787 [TBL] [Abstract][Full Text] [Related]
38. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT. Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387 [TBL] [Abstract][Full Text] [Related]